Cargando…

It Is Necessary to Purpose an Add-on to the American Classification of Endometriosis? This Disease Can Be Compared to a Malignant Proliferation While Remaining Benign in Most Cases. EndoGram® Is a New Profile Witness of Its Evolutionary Potential

Endometriosis is a curious pathology that has been the topic of many international publications. Its etiology remains mysterious but seems to have multiple causes. It is a complex disease whose lesions are very heterogeneous in where they can occur (deep endometriosis, superficial, ovarian cyst), ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouquet de Joliniere, Jean, Major, Attila, Ayoubi, Jean Marc, Cabry, Rosalie, Khomsi, Fathi, Lesec, Guy, Frydman, René, Feki, Anis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566301/
https://www.ncbi.nlm.nih.gov/pubmed/31231658
http://dx.doi.org/10.3389/fsurg.2019.00027
_version_ 1783426822641287168
author Bouquet de Joliniere, Jean
Major, Attila
Ayoubi, Jean Marc
Cabry, Rosalie
Khomsi, Fathi
Lesec, Guy
Frydman, René
Feki, Anis
author_facet Bouquet de Joliniere, Jean
Major, Attila
Ayoubi, Jean Marc
Cabry, Rosalie
Khomsi, Fathi
Lesec, Guy
Frydman, René
Feki, Anis
author_sort Bouquet de Joliniere, Jean
collection PubMed
description Endometriosis is a curious pathology that has been the topic of many international publications. Its etiology remains mysterious but seems to have multiple causes. It is a complex disease whose lesions are very heterogeneous in where they can occur (deep endometriosis, superficial, ovarian cyst), extent, associated symptoms, evolution or aggressiveness of the disease, and response to treatments. Furthermore, it evolves in pushes, remains autonomous, and is responsible for both superficial and deep lesions that explain its two most well know challenges: pain and infertility. It has always been classified by the size of its anatomical lesions—Acosta classification (1), revised by the American fertility society (AFS) (2), and the American society of reproductive medicine (ASRM) classification with a description of the disease at different stages: minimal (score of 1 to 5), mild (3–12), moderate (16 to 40), and severe (>40) (13). If this classification provides a complete repertoire of implants (anatomic) (10), the attribution of points is arbitrary. In fact, the size of the lesions is not synonymous with the difficulty to treat them surgically. Their location, if deep, is larger than the size of ovarian endometriomas. In addition, small anatomical but evaluative lesions will have a larger impact than big fibrous and stable lesions (Figure 1). Thus, attempts to explain their inflammatory side effects have been proposed (14, 15). The French classification nodule, ovaries, adhesions, tube, and inflammation (FOATI) (10) has had the merit of taking this phenomenon into account. In our opinion, we must go much further and propose an amendment in this classification, taking into account the evolution of the lesions and their deep molecular biology because in reality, the lesions are not at the same stage.
format Online
Article
Text
id pubmed-6566301
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65663012019-06-21 It Is Necessary to Purpose an Add-on to the American Classification of Endometriosis? This Disease Can Be Compared to a Malignant Proliferation While Remaining Benign in Most Cases. EndoGram® Is a New Profile Witness of Its Evolutionary Potential Bouquet de Joliniere, Jean Major, Attila Ayoubi, Jean Marc Cabry, Rosalie Khomsi, Fathi Lesec, Guy Frydman, René Feki, Anis Front Surg Surgery Endometriosis is a curious pathology that has been the topic of many international publications. Its etiology remains mysterious but seems to have multiple causes. It is a complex disease whose lesions are very heterogeneous in where they can occur (deep endometriosis, superficial, ovarian cyst), extent, associated symptoms, evolution or aggressiveness of the disease, and response to treatments. Furthermore, it evolves in pushes, remains autonomous, and is responsible for both superficial and deep lesions that explain its two most well know challenges: pain and infertility. It has always been classified by the size of its anatomical lesions—Acosta classification (1), revised by the American fertility society (AFS) (2), and the American society of reproductive medicine (ASRM) classification with a description of the disease at different stages: minimal (score of 1 to 5), mild (3–12), moderate (16 to 40), and severe (>40) (13). If this classification provides a complete repertoire of implants (anatomic) (10), the attribution of points is arbitrary. In fact, the size of the lesions is not synonymous with the difficulty to treat them surgically. Their location, if deep, is larger than the size of ovarian endometriomas. In addition, small anatomical but evaluative lesions will have a larger impact than big fibrous and stable lesions (Figure 1). Thus, attempts to explain their inflammatory side effects have been proposed (14, 15). The French classification nodule, ovaries, adhesions, tube, and inflammation (FOATI) (10) has had the merit of taking this phenomenon into account. In our opinion, we must go much further and propose an amendment in this classification, taking into account the evolution of the lesions and their deep molecular biology because in reality, the lesions are not at the same stage. Frontiers Media S.A. 2019-06-07 /pmc/articles/PMC6566301/ /pubmed/31231658 http://dx.doi.org/10.3389/fsurg.2019.00027 Text en Copyright © 2019 Bouquet de Joliniere, Major, Ayoubi, Cabry, Khomsi, Lesec, Frydman and Feki. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Bouquet de Joliniere, Jean
Major, Attila
Ayoubi, Jean Marc
Cabry, Rosalie
Khomsi, Fathi
Lesec, Guy
Frydman, René
Feki, Anis
It Is Necessary to Purpose an Add-on to the American Classification of Endometriosis? This Disease Can Be Compared to a Malignant Proliferation While Remaining Benign in Most Cases. EndoGram® Is a New Profile Witness of Its Evolutionary Potential
title It Is Necessary to Purpose an Add-on to the American Classification of Endometriosis? This Disease Can Be Compared to a Malignant Proliferation While Remaining Benign in Most Cases. EndoGram® Is a New Profile Witness of Its Evolutionary Potential
title_full It Is Necessary to Purpose an Add-on to the American Classification of Endometriosis? This Disease Can Be Compared to a Malignant Proliferation While Remaining Benign in Most Cases. EndoGram® Is a New Profile Witness of Its Evolutionary Potential
title_fullStr It Is Necessary to Purpose an Add-on to the American Classification of Endometriosis? This Disease Can Be Compared to a Malignant Proliferation While Remaining Benign in Most Cases. EndoGram® Is a New Profile Witness of Its Evolutionary Potential
title_full_unstemmed It Is Necessary to Purpose an Add-on to the American Classification of Endometriosis? This Disease Can Be Compared to a Malignant Proliferation While Remaining Benign in Most Cases. EndoGram® Is a New Profile Witness of Its Evolutionary Potential
title_short It Is Necessary to Purpose an Add-on to the American Classification of Endometriosis? This Disease Can Be Compared to a Malignant Proliferation While Remaining Benign in Most Cases. EndoGram® Is a New Profile Witness of Its Evolutionary Potential
title_sort it is necessary to purpose an add-on to the american classification of endometriosis? this disease can be compared to a malignant proliferation while remaining benign in most cases. endogram® is a new profile witness of its evolutionary potential
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566301/
https://www.ncbi.nlm.nih.gov/pubmed/31231658
http://dx.doi.org/10.3389/fsurg.2019.00027
work_keys_str_mv AT bouquetdejolinierejean itisnecessarytopurposeanaddontotheamericanclassificationofendometriosisthisdiseasecanbecomparedtoamalignantproliferationwhileremainingbenigninmostcasesendogramisanewprofilewitnessofitsevolutionarypotential
AT majorattila itisnecessarytopurposeanaddontotheamericanclassificationofendometriosisthisdiseasecanbecomparedtoamalignantproliferationwhileremainingbenigninmostcasesendogramisanewprofilewitnessofitsevolutionarypotential
AT ayoubijeanmarc itisnecessarytopurposeanaddontotheamericanclassificationofendometriosisthisdiseasecanbecomparedtoamalignantproliferationwhileremainingbenigninmostcasesendogramisanewprofilewitnessofitsevolutionarypotential
AT cabryrosalie itisnecessarytopurposeanaddontotheamericanclassificationofendometriosisthisdiseasecanbecomparedtoamalignantproliferationwhileremainingbenigninmostcasesendogramisanewprofilewitnessofitsevolutionarypotential
AT khomsifathi itisnecessarytopurposeanaddontotheamericanclassificationofendometriosisthisdiseasecanbecomparedtoamalignantproliferationwhileremainingbenigninmostcasesendogramisanewprofilewitnessofitsevolutionarypotential
AT lesecguy itisnecessarytopurposeanaddontotheamericanclassificationofendometriosisthisdiseasecanbecomparedtoamalignantproliferationwhileremainingbenigninmostcasesendogramisanewprofilewitnessofitsevolutionarypotential
AT frydmanrene itisnecessarytopurposeanaddontotheamericanclassificationofendometriosisthisdiseasecanbecomparedtoamalignantproliferationwhileremainingbenigninmostcasesendogramisanewprofilewitnessofitsevolutionarypotential
AT fekianis itisnecessarytopurposeanaddontotheamericanclassificationofendometriosisthisdiseasecanbecomparedtoamalignantproliferationwhileremainingbenigninmostcasesendogramisanewprofilewitnessofitsevolutionarypotential